Write your message
Volume 6, Issue 4 (Fall 2021)                   J Obstet Gynecol Cancer Res 2021, 6(4): 167-173 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Madhubala M, Shukul M, Kasthuri C. Caesarean Myomectomy to Prevent Immediate or Interval Myomectomy, Hysterectomy and Postpartum Hemorrhage. J Obstet Gynecol Cancer Res. 2021; 6 (4) :167-173
URL: http://jogcr.com/article-1-342-en.html
1- Department of Obstetrics and Gynecology, Lakshmi Madhavan Hospital, Tamilnadu, India , drmbm25@gmail.com
2- Department of Obstetrics and Gynecology, Lakshmi Madhavan Hospital, Tamilnadu, India
Abstract:   (191 Views)

Background & Objective: Uterine fibroids (UF) in pregnancy is a condition, where symptomatic or asymptomatic fibroids in the uterine cavity may cause complications in pregnancies. Placental abruption and preterm labor, occurs in late pregnancy, postpartum hemorrhage, caesarean section and retained placenta in perinatal period. This study aimed to reckon whether the surgical Caesarean myomectomy is still a gold standard in myoma removal in pregnant women.
Materials & Methods: This study was retrospectively conducted in pregnant women deliveries with uterine fibroids who underwent Myomectomy with lower segment caesarean section (LSCS). The caesarean myomectomy cases were compared with LSCS alone controls in 1:2 ratio. The primary outcome is to minimize blood loss and need for blood transfusion. The secondary outcome is the length of surgery duration and hospital stay.
Results: The outcome of case and control compared was 43 caesarean myomectomy with LSCS as case group and 86 LSCS Alone as control group. The incidence of hemorrhage in case group was 10 out of 43 while control was 2 out of 86 (2.32%) with P-value of 0.0017. The secondary outcome was the length of surgery duration and hospital stay which were found statistically significant between the case and control groups, with P-value = 0.0001 and 0.0072, respectively.
Conclusion: Caesarean Myomectomy can be the effective surgical option to enucleate uterine myoma, and preserve uterus and jettison from eventful or symptomatic uterine fibroids. To have the chances for prevention of immediate or interval - myomectomy / hysterectomy and control of post-partum menstrual over bleeding.

Full-Text [PDF 494 kb]   (46 Downloads) |   |   Full-Text (HTML)  (18 Views)  
Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2021/02/12 | Accepted: 2021/04/15 | Published: 2021/08/11

1. Friedman AJ, Haas ST. Should uterine size be an indication for surgical intervention in women with myomas?. Am J Obstet Gynecol 1993; 168: 751-5. [DOI:10.1016/S0002-9378(12)90813-3]
2. Vitagliano A, Noventa M, Sardo AD, Saccone G, Gizzo S, Borgato S, et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch Gynecol Obstet. 2018; 297(4):823-35. [DOI:10.1007/s00404-017-4621-4] [PMID]
3. De Vivo A, Mancuso A, Giacobbe A, Maggio Savasta L, De Dominici R, Dugo N, et al. Uterine myomas during pregnancy: a longitudinal sonographic study. Ultrasound in obstetrics & gynecology. 2011; 37(3):361-5. [DOI:10.1002/uog.8826] [PMID]
4. Benaglia L, Cardellicchio L, Filippi F, Paffoni A, Vercellini P, Somigliana E, et al. The rapid growth of fibroids during early pregnancy. PLoS One. 2014; 9(1):e85933. [DOI:10.1371/journal.pone.0085933] [PMID] [PMCID]
5. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women's Health. 2012; 12(1):1-1. [DOI:10.1186/1472-6874-12-6] [PMID] [PMCID]
6. Ezzedine D, Norwitz ER. Are women with uterine fibroids at increased risk for adverse pregnancy outcome?. Clin Obstet Gynecol. 2016; 59(1):119-27. [DOI:10.1097/GRF.0000000000000169] [PMID]
7. Guo XC, Segars JH. The impact and management of fibroids for fertility: an evidence-based approach. Obstet Gynecol Clin North Am. 2012; 39(4): 521-33. [DOI:10.1016/j.ogc.2012.09.005] [PMID] [PMCID]
8. Dancz CE, Kadam P, Li C, Nagata K, Ozel B. The relationship between uterine leiomyomata and pelvic floor symptoms. Int Urogynecol J. 2014; 25(2): 241-8. [DOI:10.1007/s00192-013-2183-y] [PMID]
9. Moshesh M, Peddada SD, Cooper T, Baird D. Intra-Observer Variation in Fibroid Size Measurements: Estimated Effects on Assessing Fibroid Growth. J Ultrasound Med. 2014; 33(7): 1217-24. [DOI:10.7863/ultra.33.7.1217] [PMID] [PMCID]
10. Islam MS, Protic O, Giannubilo SR, Toti P, Tranquilli AL, Petraglia F, et al. Uterine Leiomyoma: Available Medical Treatments and New Possible Therapeutic Options. J Clin Endocrinol Metab. 2013; 98(3):921-34. [DOI:10.1210/jc.2012-3237] [PMID]
11. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016; 22(6): 665-86. [DOI:10.1093/humupd/dmw023] [PMID] [PMCID]
12. Klatsky PC, Tran ND, Caughey AB, FujimotoVY. Fibroids and reproductive outcomes: asystematic literature review from conception to delivery. Am J Obstet Gynecol. 2008; 198(4): 357-66. [DOI:10.1016/j.ajog.2007.12.039] [PMID]
13. Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet. 2005; 273(1):50-4. [DOI:10.1007/s00404-005-0729-z] [PMID]
14. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91(4): 1215-23. [DOI:10.1016/j.fertnstert.2008.01.051] [PMID]
15. Stewart EA, Cookson CL, Gandolfo RA, Schulze‐Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG: Int J Obstet Gynaecol. 2017; 124(10):1501-12. [DOI:10.1111/1471-0528.14640] [PMID]
16. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: A critical analysis of the evidence. Hum Reprod Update. 2007; 13(5): 465-76. [DOI:10.1093/humupd/dmm013] [PMID]
17. Benson CB, Chow JS, Chang-Lee W, Hill JA 3rd, Doubilet PM. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester. J Clin Ultrasound. 2001; 29(5): 261-4. [DOI:10.1002/jcu.1031] [PMID]
18. Vergani P, Locatelli A, Ghidini A, Andreani M, Sala F, Pezullo JC. Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol. 2007; 109(2): 410-14. [DOI:10.1097/01.AOG.0000250470.78700.f0] [PMID]
19. Munro MG, Critchley HO, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011; 95(7): 2204-8 [DOI:10.1016/j.fertnstert.2011.03.079] [PMID]
20. Friedman AJ, Rein MS, Harrison-Atlas D, Garfield JM, Doubilet PM. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril. 1989; 52(5): 728-33. [DOI:10.1016/S0015-0282(16)61022-1]
21. Xu Q, Qiu L, Zhu L, Luo L, Xu C. Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells. Contraception. 2010; 82(3):301-8. [DOI:10.1016/j.contraception.2010.03.002] [PMID]
22. Carbonell Esteve JL, Acosta R, Heredia B, Perez Y, Castaneda MC, Hernandez AV. Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial. Obstet Gynecol. 2008; 112(5): 1029-36. [DOI:10.1097/AOG.0b013e31818aa930] [PMID]
23. Gurates B, Parmaksiz C, Kilic G, Celik H, Kumru S, Simsek M. Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online. 2008; 17(4): 569 -74. [DOI:10.1016/S1472-6483(10)60246-5]
24. Marshburn PB, Matthews ML, Hurst BS. Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin North Am. 2006; 33(1):125-44. [DOI:10.1016/j.ogc.2005.12.009] [PMID]
25. Istre O. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol. 2008; 22(4):735-47. [DOI:10.1016/j.bpobgyn.2008.01.010] [PMID]
26. Vitale SG, Padula F, Gulino FA. Management of uterine fibroids in pregnancy: recent trends. Curr Opin Obstet Gynecol. 2015; 27(6):432-7. [DOI:10.1097/GCO.0000000000000220] [PMID]
27. Senturk MB, Polat M, Doğan O, Pulatoğlu Ç, Yardımcı OD, Karakuş R, et al. Outcome of Cesarean Myomectomy: Is it a Safe Procedure? Geburtshilfe Frauenheilkd 2017; 77(11):1200-6. [DOI:10.1055/s-0043-120918] [PMID] [PMCID]
28. Stout MJ, Odibo AO, Graseck AS, Macones GA, Crane JP, Cahill AG. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol. 2010; 116:1056-63. [DOI:10.1097/AOG.0b013e3181f7496d] [PMID]
29. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol. 2009; 113(3):630-5. [DOI:10.1097/AOG.0b013e318197bbaf] [PMID] [PMCID]
30. Hammoud AO, Asaad R, Berman J, Treadwell MC, Blackwell S, Diamond MP. Volume change of uterine myomas during pregnancy: do myomas really grow? J Minim Invasive Gynecol. 2006; 13(5):386-90. [DOI:10.1016/j.jmig.2006.04.003] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.